SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-13-000558
Filing Date
2013-03-29
Accepted
2013-03-29 12:53:46
Documents
7
Period of Report
2013-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cdxc8kmar272013.htm 8-K 29843
2 ASSET PURCHASE AND SALE AGREEMENT BY AND BETWEEN CHROMADEX CORPORATION AND NEUTR ex10-1.htm EX-10.1 282298
3 SENIOR SECURED CONVERTIBLE PROMISSORY NOTE ex10-2.htm EX-10.2 172244
4 SECURITY AGREEMENT BY AND BETWEEN CHROMADEX CORPORATION AND NEUTRISCI INTERNATIO ex10-3.htm EX-10.3 171675
5 SUBSIDIARY GUARANTY EXECUTED BY BRITLOR HEALTH AND WELNESS, INC. ex10-4.htm EX-10.4 80589
6 ROYALTY AGREEMENT BY AND BETWEEN CHROMADEX CORPORATION AND NEUTRISCI INTERNATION ex10-5.htm EX-10.5 57508
7 SALES CONFIRMATION AND CONTRACT BY AND BETWEEN CHROMADEX CORPORATION AND NEUTRIS ex10-6.htm EX-10.6 45019
  Complete submission text file 0001415889-13-000558.txt   840429
Mailing Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618
Business Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618 949-419-0288
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53290 | Film No.: 13727048
SIC: 2833 Medicinal Chemicals & Botanical Products